November 13, 2018
Rose
Health Care, THCB
No comments
Related Posts:
The Other Opioid EpidemicBy HANS DUVEFELT, MD “I made myself a hypodermic injection of a triple dose of morphia and sank down on the couch in my consulting-room….I told her I was all right, all I wanted was twenty-four hours’ sleep, she was not to d… Read More
The Death of ObjectivityBy MICHAEL TURPIN For veterans of the healthcare industry, the current debate over the future of the Affordable Care Act – and proposed changes that would fundamentally alter Medicaid and individual market exchanges – is a fr… Read More
Matthew Holt’s EOY 2017 letter (charities/issues/gossip)Right at the end of every year I write a letter summarizing my issues and charities. And as I own the joint here, I post it on THCB! Please take a look–Matthew Holt Well 2017 has been quite a year, and last year 2016 I failed… Read More
Your Ticket to an Intimate Chat With Health Tech VCsThere’s so much news from media outlets and bloggers about the next Health Tech investment treads that its difficult to pin point where to focus or what will materialize. Its much easier when you can actually hear the treads … Read More
The Political Economy of FentanylBy KAREN SIBERT, MD Just say No to Fentanyl. No, I’m not talking about putting fentanyl into my own veins — a remarkably bad idea. I’m questioning the habitual, reflex use of fentanyl, a synthetic opioid, in clinical anesthes… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment